Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Durability of platelet inhibition by clopidogrel.

× No keyword cloud information.

15 in total

1. Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers.

Authors: Kathleen Butler; Renli Teng
Journal: Br J Clin Pharmacol Date: 2010-07 Impact factor: 4.335

2. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy.

Authors: A Anil Timur; Gurunathan Murugesan; Li Zhang; John Barnard; Deepak L Bhatt; Kandice Kottke-Marchant
Journal: Thromb Res Date: 2014-04-29 Impact factor: 3.944

Review 3. Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4.

Authors: Wei C Lau; Paul A Gurbel
Journal: Pharm Res Date: 2006-10-24 Impact factor: 4.200

Review 4. Antiplatelet resistance with aspirin and clopidogrel: is it real and does it matter?

Authors: Wai-Hong Chen
Journal: Curr Cardiol Rep Date: 2006-07 Impact factor: 2.931

5. A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans.

Authors: Joseph A Jakubowski; Nobuko Matsushima; Fumitoshi Asai; Hideo Naganuma; John T Brandt; Takashi Hirota; Stephen Freestone; Kenneth J Winters
Journal: Br J Clin Pharmacol Date: 2006-10-31 Impact factor: 4.335

Review 6. Secondary prevention strategies for coronary heart disease.

Authors: Shepard D Weiner; LeRoy E Rabbani
Journal: J Thromb Thrombolysis Date: 2010-01 Impact factor: 2.300

Review 7. Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.

Authors: Saurav Chatterjee; Abhimanyu Ghose; Abhishek Sharma; Gunjan Guha; Debabrata Mukherjee; Robert Frankel
Journal: J Thromb Thrombolysis Date: 2013-10 Impact factor: 2.300

8. Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.

Authors: Renli Teng; Kathleen Butler
Journal: Eur J Clin Pharmacol Date: 2010-01-21 Impact factor: 2.953

9. Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.

Authors: Vedat Davutoglu; Serdar Soydinc; Yusuf Sezen
Journal: J Thromb Thrombolysis Date: 2003-02 Impact factor: 2.300

Review 10. Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.

Authors: Steen Husted; J J J van Giezen
Journal: Cardiovasc Ther Date: 2009 Impact factor: 3.023